Hildebran C[au] - Search Results

Year	Number of Results
2014	2
2015	1
2016	3
2017	4
2018	8
2019	1
2020	4
2021	4

1

Reply.

Geissert P, Hallvik S, O'Kane N, Van Otterloo J, Alley L, Carson J, Leichtling G, Hildebran C, Wakeland W, Deyo RA. Geissert P, et al. Among authors: hildebran c. Pain. 2018 Apr;159(4):805-806. doi: 10.1097/j.pain.0000000000001156. Pain. 2018. PMID: 29557902 Free PMC article. No abstract available.

2

Association Between Initial Opioid Prescribing Patterns and Subsequent Long-Term Use Among Opioid-Naïve Patients: A Statewide Retrospective Cohort Study.

Deyo RA, Hallvik SE, Hildebran C, Marino M, Dexter E, Irvine JM, O'Kane N, Van Otterloo J, Wright DA, Leichtling G, Millet LM. Deyo RA, et al. Among authors: hildebran c. J Gen Intern Med. 2017 Jan;32(1):21-27. doi: 10.1007/s11606-016-3810-3. Epub 2016 Aug 2. J Gen Intern Med. 2017. PMID: 27484682 Free PMC article.

3

Response to "Naturopathic Physician Prescribing Patterns in Oregon".

Fink PB, Deyo RA, Hallvik SE, Hildebran C. Fink PB, et al. Among authors: hildebran c. Pain Med. 2019 Feb 1;20(2):416. doi: 10.1093/pm/pny047. Pain Med. 2019. PMID: 29546430 Free PMC article. No abstract available.

4

Physician Responses to Enhanced Prescription Drug Monitoring Program Profiles.

Leichtling G, Hildebran C, Novak K, Alley L, Doyle S, Reilly C, Weiner SG. Leichtling G, et al. Among authors: hildebran c. Pain Med. 2020 Feb 1;21(2):e9-e21. doi: 10.1093/pm/pny291. Pain Med. 2020. PMID: 30698811

5

Opioid-Prescribing Continuity and Risky Opioid Prescriptions.

Hallvik SE, Geissert P, Wakeland W, Hildebran C, Carson J, O'Kane N, Deyo RA. Hallvik SE, et al. Among authors: hildebran c. Ann Fam Med. 2018 Sep;16(5):440-442. doi: 10.1370/afm.2285. Ann Fam Med. 2018. PMID: 30201641 Free PMC article.

6

Impact of the RESPOND Toolkit on community pharmacists' opioid safety attitudes, self-efficacy, and knowledge.

Irwin AN, Novak K, Alley L, Havlin T, O'Kane N, Johnston K, Hildebran C, Carson J, Hartung DM. Irwin AN, et al. Among authors: hildebran c. J Am Pharm Assoc (2003). 2020 May-Jun;60(3):450-455.e3. doi: 10.1016/j.japh.2019.11.030. Epub 2020 Jan 7. J Am Pharm Assoc (2003). 2020. PMID: 31919007

7

Prescription Opioid Dispensing Patterns Prior to Heroin Overdose in a State Medicaid Program: a Case-Control Study.

Hartung DM, Johnston KA, Hallvik S, Leichtling G, Geddes J, Hildebran C, Keast S, Chan B, Korthuis PT. Hartung DM, et al. Among authors: hildebran c. J Gen Intern Med. 2020 Nov;35(11):3188-3196. doi: 10.1007/s11606-020-06192-4. Epub 2020 Sep 15. J Gen Intern Med. 2020. PMID: 32935311

8

Pharmacists' Role in Opioid Safety: A Focus Group Investigation.

Hartung DM, Hall J, Haverly SN, Cameron D, Alley L, Hildebran C, O'Kane N, Cohen D. Hartung DM, et al. Among authors: hildebran c. Pain Med. 2018 Sep 1;19(9):1799-1806. doi: 10.1093/pm/pnx139. Pain Med. 2018. PMID: 29016883 Free PMC article.

9

Reducing overdose after release from incarceration (ROAR): study protocol for an intervention to reduce risk of fatal and non-fatal opioid overdose among women after release from prison.

Waddell EN, Baker R, Hartung DM, Hildebran CJ, Nguyen T, Collins DM, Larsen JE, Stack E; ROAR Protocol Development Team. Waddell EN, et al. Among authors: hildebran cj. Health Justice. 2020 Jul 10;8(1):18. doi: 10.1186/s40352-020-00113-7. Health Justice. 2020. PMID: 32651887 Free PMC article.

10

Research to support optimization of prescription drug monitoring programs.

Doyle S, Leichtling G, Hildebran C, Reilly C. Doyle S, et al. Among authors: hildebran c. Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1425-1427. doi: 10.1002/pds.4300. Epub 2017 Sep 14. Pharmacoepidemiol Drug Saf. 2017. PMID: 28905438

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results